+987.9%
MRNA vs KMX
+35.0%
+952.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | KMX | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +3.3% | +9.8% | +12.2% |
| 7D | +20.6% | +2.1% | +18.5% | +19.9% |
| 30D | +27.1% | +0.5% | +26.6% | +26.5% |
| 3M | +353.4% | -4.1% | +357.5% | +359.2% |
| 6M | +446.3% | +49.5% | +396.7% | +414.3% |
| YTD | +776.2% | +42.7% | +733.5% | +733.6% |
| 1Y | +987.9% | +35.3% | +952.6% | +935.2% |
| All | +987.9% | +35.0% | +952.9% | +935.2% |
Cumulative growth
Daily Returns
Daily percentage return beside KMX.
Daily Out/Under-Performance
Portfolio return minus KMX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × KMX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded KMX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling